Ondansetron
- Product NDC
- 55154-3680
- 11-digit product format
- 551543680
- Labeler code
- 55154
- Product ID
- 55154-3680_6ce0d9b0-1ce4-4870-b134-cc3ea1187af6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ondansetron
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- Cardinal Health 107, LLC
- Application
- ANDA078152
- Marketing category
- ANDA
- Marketing start
- 2007-06-27
- Substance
- ONDANSETRON
- Active strength
- 4 mg/1
- Pharmacologic classes
- Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ondansetron
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ONDANSETRON | 4 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 4AF302ESOS |
| Rxcui | 104894 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 55154-3680-0 | Ondansetron | 10 in 1 BAG | TABLET, ORALLY DISINTEGRATING | 10 | | 12 |
| 55154-3680-0 | Ondansetron | 1 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 1 | | 12 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ONDANSETRON | ACTIVE INGREDIENT | 4AF302ESOS | ONDANSETRON TABLET, ORALLY DISINTEGRATING [CARDINAL HEALTH] | 3 | |
| ONDANSETRON | ACTIVE MOIETY | 4AF302ESOS | ONDANSETRON TABLET, ORALLY DISINTEGRATING [CARDINAL HEALTH] | 3 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | ONDANSETRON TABLET, ORALLY DISINTEGRATING [CARDINAL HEALTH] | 3 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | ONDANSETRON TABLET, ORALLY DISINTEGRATING [CARDINAL HEALTH] | 3 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ONDANSETRON TABLET, ORALLY DISINTEGRATING [CARDINAL HEALTH] | 3 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | ONDANSETRON TABLET, ORALLY DISINTEGRATING [CARDINAL HEALTH] | 3 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ONDANSETRON TABLET, ORALLY DISINTEGRATING [CARDINAL HEALTH] | 3 | |
| SODIUM STEARYL FUMARATE | INACTIVE INGREDIENT | 7CV7WJK4UI | ONDANSETRON TABLET, ORALLY DISINTEGRATING [CARDINAL HEALTH] | 3 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 55154-3680 | ONDANSETRON TABLET, ORALLY DISINTEGRATING [CARDINAL HEALTH 107, LLC] | 10 | Current NDC, Legacy NDC, 2 package rows | 20240207_3c34ca82-9705-4784-be7c-8b50351d14fc.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 55154-3680-0 | 55154368000 | 10 BLISTER PACK in 1 BAG (55154-3680-0) / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK | 10 blister pack | 2007-06-27 | 0000-00-00 | No | No | Current |